Next Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib Sensitive ALK Rearrangement in a Patient with Metastatic Non-small Cell Lung Cancer

Por Peled, Nir, Palmer, Gary, Hirsch, Fred R., Wynes, Murry W., Ilouze, Maya, Varella-Garcia, Marileila, Soussan-Gutman, Lior, Otto, Geoff A., Stephens, Philip J., Ross, Jeffrey S., Cronin, Maureen T., Lipson, Doron, Miller, Vincent A.
Publicado em 2012

Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

Por Vo, Kieuhoa T., Matthay, Katherine K., Neuhaus, John, London, Wendy B., Hero, Barbara, Ambros, Peter F., Nakagawara, Akira, Miniati, Doug, Wheeler, Kate, Pearson, Andrew D.J., Cohn, Susan L., DuBois, Steven G.
Publicado em 2014

Enhancing value of quality assurance rounds in improving radiotherapy management: a retrospective analysis from King Hussein Cancer Center in Jordan

Por Khader, Jamal K., Al-Mousa, Abdelatif M., Mohamad, Issa A., Abuhijlih, Ramiz A., Al-Khatib, Sondos A., Alnsour, Anoud Z., Asha, Wafa A., Ramahi, Shada W., Hosni, Ali A., Abuhijla, Fawzi J.
Publicado no Radiat Oncol J (2019)

Systemic Therapy, Clinical Outcomes, and Overall Survival in Locally Advanced or Metastatic Pulmonary Carcinoid: A Brief Report

Por Forde, Patrick M., Hooker, Craig M., Boikos, Sosipatros A., Petrini, Iacope, Giaccone, Giuseppe, Rudin, Charles M., Yang, Stephen C., Illei, Peter B., Hann, Christine L., Ettinger, David S., Brahmer, Julie R., Kelly, Ronan J.
Publicado no J Thorac Oncol (2014)

Radioprotection of Lung Tissue by Soy Isoflavones

Por Hillman, Gilda G., Singh-Gupta, Vinita, Lonardo, Fulvio, Hoogstra, David J., Abernathy, Lisa M., Yunker, Christopher K., Rothstein, Shoshana E., Rakowski, Joseph, Sarkar, Fazlul H., Gadgeel, Shirish, Konski, Andre A., Joiner, Michael C.
Publicado em 2013

Primary Lung Adenocarcinomas in Children and Adolescents Treated for Pediatric Malignancies

Por Kayton, Mark L., He, Mai, Zakowski, Maureen F., Moreira, Andre L., Lau, Christopher, Chou, Alexander J., Merchant, Melinda, Merola, Pamela R., Wexler, Leonard H., La Quaglia, Michael P., Travis, William D., Ladanyi, Marc
Publicado no J Thorac Oncol (2010)

Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma

Por Shaikh, Fauzia, Zauderer, Marjorie G., von Reibnitz, Donata, Wu, Abraham J., Yorke, Ellen D., Foster, Amanda, Shi, Weiji, Zhang, Zhigang, Adusumilli, Prasad S., Rosenzweig, Kenneth E., Krug, Lee M., Rusch, Valerie W., Rimner, Andreas
Publicado no J Thorac Oncol (2017)

G-Protein Coupled Receptor Family C, Group 5, Member A (GPRC5A) Expression Is Decreased in the Adjacent Field and Normal Bronchial Epithelia of Patients with Chronic Obstructive Pu...

Por Fujimoto, Junya, Kadara, Humam, Garcia, Melinda M., Kabbout, Mohamed, Behrens, Carmen, Liu, Diane D., Lee, J. Jack, Solis, Luisa M., Kim, Edward S., Kalhor, Neda, Moran, Cesar, Sharafkhaneh, Amir, Lotan, Reuben, Wistuba, Ignacio I.
Publicado em 2012

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Por Choong, Nicholas W., Mauer, Ann M., Haraf, Daniel J., Lester, Eric, Hoffman, Philip C., Kozloff, Mark, Lin, Shang, Dancey, Janet E., Szeto, Livia, Grushko, Tatyana, Olopade, Olufunmilayo I., Salgia, Ravi, Vokes, Everett E.
Publicado no J Thorac Oncol (2008)

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Por Arriola, Edurne, Wheater, Matthew, Galea, Ian, Cross, Nadia, Maishman, Tom, Hamid, Debbie, Stanton, Louise, Cave, Judith, Geldart, Tom, Mulatero, Clive, Potter, Vannessa, Danson, Sarah, Woll, Pennella J., Griffiths, Richard, Nolan, Luke, Ottensmeier, Christian
Publicado no J Thorac Oncol (2016)

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without...

Por Govindan, Ramaswamy, Bogart, Jeffrey, Stinchcombe, Thomas, Wang, Xiaofei, Hodgson, Lydia, Kratzke, Robert, Garst, Jennifer, Brotherton, Timothy, Vokes, Everett E.
Publicado em 2011

E-Cigarettes and Cancer Patients

Por Cummings, K. Michael, Dresler, Carolyn M., Field, John K., Fox, Jesme, Gritz, Ellen R., Hanna, Nasser H., Ikeda, Norihiko, Jassem, Jacek, Mulshine, James L., Peters, Matthew J., Yamaguchi, Nise H., Warren, Graham, Zhou, Caicun
Publicado em 2014

Brief Report: A Phase II “Window-of-Opportunity” Frontline Study of the mTOR Inhibitor, Temsirolimus Given as a Single Agent in Patients with Advanced NSCLC, an NCCTG Study

Por Reungwetwattana, Thanyanan, Molina, Julian R., Mandrekar, Sumithra J., Allen-Ziegler, Katie, Rowland, Kendrith M., Reuter, Nicholas F., Luyun, Ronnie F., Dy, Grace K., Marks, Randolph S., Schild, Steven E., Jett, James R., Adjei, Alex A.
Publicado no J Thorac Oncol (2012)

Clinical and Biomarker Outcomes of the Phase II Vandetanib Study from the BATTLE Trial

Por Tsao, Anne S., Liu, Suyu, Lee, J. Jack, Alden, Christine M., Blumenschein, George R., Herbst, Roy, Davis, Suzanne E., Kim, Edward, Lippman, Scott, Heymach, John, Tran, Hai, Tang, XiMing, Wistuba, Ignacio, Hong, Waun Ki
Publicado no J Thorac Oncol (2013)

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors

Por Albany, C, Adra, N, Snavely, A C, Cary, C, Masterson, T A, Foster, R S, Kesler, K, Ulbright, T M, Cheng, L, Chovanec, M, Taza, F, Ku, K, Brames, M J, Hanna, N H, Einhorn, L H
Publicado no Ann Oncol (2018)

Persistent left superior vena cava: Review of the literature, clinical implications, and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous...

Por Povoski, Stephen P, Khabiri, Hooman
Publicado em 2011

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor...

Por Lilenbaum, Rogerio, Samuels, Michael, Wang, Xiaofei, Kong, Feng Ming, Jänne, Pasi A., Masters, Gregory, Katragadda, Sreedhar, Hodgson, Lydia, Bogart, Jeffrey, Bradley, Jeffrey, Vokes, Everett
Publicado no J Thorac Oncol (2015)

A phase II study of halichondrin B analogue eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California Cancer Con...

Por Gitlitz, Barbara J, Tsao-Wei, Denice D, Groshen, Susan, Davies, Angela, Koczywas, Marianna, Belani, Chandra P, Argiris, Athanassios, Ramalingam, Suresh, Vokes, Everett E, Edelman, Martin, Hoffman, Philip, Ballas, Marc S, Liu, Stephen V, Gandara, David R
Publicado em 2012

Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EGFR tyr...

Por Yu, Helena A., Sima, Camelia S., Huang, James, Solomon, Stephen B., Rimner, Andreas, Paik, Paul, Pietanza, M. Catherine, Azzoli, Christopher G., Rizvi, Naiyer A., Krug, Lee M., Miller, Vincent A., Kris, Mark G., Riely, Gregory J.
Publicado em 2013

Significance of Folate Receptor alpha and Thymidylate Synthase Protein Expression in Patients with Non-Small Cell Lung Cancer treated with Pemetrexed

Por Christoph, Daniel C, Asuncion, Bernadette Reyna, Hassan, Biftu, Tran, Cindy, Maltzman, Julia D, O’Shannessy, Daniel J, Wynes, Murry W, Gauler, Thomas C, Wohlschlaeger, Jeremias, Hoiczyk, Mathias, Schuler, Martin, Eberhardt, Wilfried E, Hirsch, Fred R
Publicado em 2013